I. Neuringer

发表

Lung progenitor and stem cell biology and therapy

I. Neuringer, 2012 .

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease.

C. Benden, J. Pilewski, B. Moshiree, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Lung Transplant: Information and Recommendations for Rehabilitation Counselors

L. Williams, E. Burker, Kelly A. Kazukauskas, 2012, Journal of Applied Rehabilitation Counseling.

Carboxylated osteocalcin levels in cystic fibrosis.

R. Aris, Sue A. Brown, G. Lester, 2003, American journal of respiratory and critical care medicine.

Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.

M. Gulley, N. Raab-Traub, R. Aris, 2008, American journal of respiratory and critical care medicine.

Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation

M. P. Rivera, R. Aris, I. Neuringer, 2006, Thorax.

Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice.

X. Hua, W. Funkhouser, A. Ghio, 2006, American journal of respiratory cell and molecular biology.

Efficacy of Alendronate in Cystic Fibrosis Adults with Low Bone Density

J. Renner, R. Lark, R. Aris, 2003 .

Efficacy of alendronate in adults with cystic fibrosis with low bone density.

J. Renner, R. Lark, R. Aris, 2004, American journal of respiratory and critical care medicine.

MyD88 provides a protective role in long-term radiation-induced lung injury

X. Hua, J. Ting, S. Kirby, 2012, International journal of radiation biology.

Lung stem cell update: promise and controversy.

S. Randell, I. Neuringer, 2016, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Effects of a primary palliative care intervention on quality of life and mental health in cystic fibrosis

S. Moskowitz, A. Georgiopoulos, L. Yonker, 2019, Pediatric pulmonology.

Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.

L. Lobo, R. Aris, J. Schmitz, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Managing complications following lung transplantation

P. Noone, R. Aris, I. Neuringer, 2009, Expert review of respiratory medicine.

Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance

J. Ting, R. Noelle, K. McKinnon, 2005, Thorax.

Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review.

R. Aris, I. Neuringer, W. Chalermskulrat, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Epithelial Kinetics in Mouse Heterotopic Tracheal Allografts

S. Randell, R. Aris, K. Burns, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis.

R. Mannon, R. Aris, I. Neuringer, 2000, Transplantation.

The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.

P. Gilligan, J. Yankaskas, R. Aris, 1997, American journal of respiratory and critical care medicine.

Bronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression.

C. Bortner, S. Garantziotis, S. Palmer, 2014, American journal of physiology. Lung cellular and molecular physiology.

Immune cells in a mouse airway model of obliterative bronchiolitis.

M. Parsons, J. Yankaskas, T. Coffman, 1998, American journal of respiratory cell and molecular biology.

‘Old’ bones in young bodies: the tale of cystic fibrosis

R. Aris, I. Neuringer, Amy A. Sparks, 2009, Current opinion in endocrinology, diabetes, and obesity.

Severe osteoporosis before and after lung transplantation.

T. Egan, R. Aris, D. Ontjes, 1996, Chest.

The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.

M. Bouxsein, C. Gordon, G. Sawicki, 2020, The Journal of clinical endocrinology and metabolism.

Celiac Disease in Patients with Cystic Fibrosis-Related Bone Disease

M. Putman, L. Sicilian, I. Neuringer, 2017, Case reports in endocrinology.

Hierarchical contributions of allorecognition pathways in chronic lung rejection.

S. Randell, J. Ting, R. Aris, 2003, American journal of respiratory and critical care medicine.

Posttransplant Lymphoproliferative Disease after Lung Transplantation

I. Neuringer, 2013, Clinical & developmental immunology.

Calcineurin Inhibitor Effects on Growth and Phenotype of Human Airway Epithelial Cells In Vitro

S. Randell, R. Aris, J. R. Stonebraker, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Single- Versus Double-Lung Transplantation in Pulmonary Fibrosis: Impact of Age and Pulmonary Hypertension.

T. Sundt, A. Osho, T. Astor, 2018, The Annals of thoracic surgery.

Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis

L. McIver, K. Whiteson, K. Hanselmann, 2022, mSystems.

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

C. Teneback, P. Sosnay, R. Klingsberg, 2019, The Lancet.

Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.

S. Randell, D. Catellier, M. Gurka, 2003, Chest.

Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis.

R. Lark, R. Aris, G. Lester, 2000, American journal of respiratory and critical care medicine.

Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis

L. McIver, K. Whiteson, K. Hanselmann, 2022, mSystems.

Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.

D. Maia, J. Handy, R. Aris, 1996, American journal of respiratory and critical care medicine.

PX3.102, a novel chinese herb extract, diminishes chronic airway allograft rejection.

S. Randell, R. Aris, I. Neuringer, 2004, Transplantation.

Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation

S. Tilley, R. Aris, I. Neuringer, 2012, Respiratory Research.

Stem cells and repair of lung injuries

S. Randell, I. Neuringer, Scott H. Randell, 2004, Respiratory research.

Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.

G. Sawicki, D. Wexler, M. Larkin, 2021, The Journal of clinical endocrinology and metabolism.

Growth factor upregulation during obliterative bronchiolitis in the mouse model.

R. Aris, I. Neuringer, W. Chalermskulrat, 2002, American journal of respiratory and critical care medicine.

Acylation reactions of phenylhydrazines. Preparation and properties of new diacylphenylhydrazines

I. Neuringer, M. Hearn, F. Levy, 1985 .

404: Cyclosporine Alters Airway Epithelial Cell Cytokine Secretion In Vitro: A Potential Mechanism To Explain the Efficacy of Inhaled Cyclosporine

R. Aris, P. McNeillie, I. Neuringer, 2008 .

Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response

R. Chung, S. Wolfe, A. Osho, 2023, JTCVS open.

Lung transplant referral practice patterns: a survey of cystic fibrosis physicians and general pulmonologists

C. Schwartz, Roland B. Stark, H. Dorkin, 2020, BMC Pulmonary Medicine.

Stem cells and repair of lung injuries

S. Randell, I. Neuringer, 2004, Respiratory research.

Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients—A Prospective Longitudinal Study

M. Goldberg, J. Lemieux, M. Seaman, 2023, Open Forum Infectious Diseases.

Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.

L. Lobo, R. Aris, J. Schmitz, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The evolving classification of chronic lung allograft dysfunction: Phenotypes and causes known and unknown.

I. Neuringer, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation

R. Aris, I. Neuringer, W. Chalermskulrat, 2006, Thorax.